- Home
- ARQT vs CPK Comparison
ARQT vs CPK Comparison
Compare ARQT & CPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARQT | CPK |
|---|---|---|
| Founded | 2016 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.9B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARQT | CPK |
|---|---|---|
| Price | $29.51 | $125.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | $24.83 | ★ $141.00 |
| AVG Volume (30 Days) | ★ 2.3M | 148.0K |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 2.17% |
| EPS Growth | N/A | ★ 14.49 |
| EPS | N/A | ★ 5.62 |
| Revenue | $317,929,000.00 | ★ $886,100,000.00 |
| Revenue This Year | $85.51 | $13.68 |
| Revenue Next Year | $30.74 | $6.12 |
| P/E Ratio | ★ N/A | $22.42 |
| Revenue Growth | ★ 129.21 | 16.97 |
| 52 Week Low | $11.13 | $115.12 |
| 52 Week High | $31.77 | $140.59 |
Technical Indicators
Market Signals| Indicator | ARQT | CPK |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 29.33 |
| Support Level | $28.95 | $134.85 |
| Resistance Level | $31.77 | $139.57 |
| Average True Range (ATR) | 1.36 | 3.07 |
| MACD | -0.14 | -1.41 |
| Stochastic Oscillator | 54.51 | 1.47 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About CPK Chesapeake Utilities Corporation
Chesapeake Utilities Corp is a diversified energy delivery company that is engaged in natural gas transmission and distribution, electricity generation and distribution, propane gas distribution, mobile compressed natural gas utility services and solutions and other businesses. The company operates in two reportable segments, Regulated Energy and Unregulated Energy. The company's natural gas and electric distribution operations in Delaware, Maryland and Florida are subject to regulation by PSC. Eastern Shore, its natural gas transmission is subject to regulation by the FERC and Peninsula Pipeline and Aspire Energy Express, its intrastate pipeline subsidiaries, are subject to regulation by the Florida PSC and Public Utilities Commission of Ohio, respectively.